abstract |
The present invention relates to formulations of 3- (6- (1- (2,2-difluorobenzo [d] [1,3] dioxol-5yl) cyclopropanecarboxamido) -3 methylpyridin-2-yl) benzoic acid in Form I , pharmaceutical packages or kits thereof, and methods of treatment with these. |